Algorithmiq is pioneering the integration of quantum computing, artificial intelligence (AI), and network science to solve the world’s most complex problems. Co-founded by Sabrina Maniscalco, Guillermo García-Pérez, Matteo Rossi, and Boris Sokolov, the company develops advanced quantum algorithms focusing on, but not limited to, Life Sciences applications to accelerate drug discovery and development. This enables faster, more precise, and cost-effective creation of precise medical treatments.